Overview
- 3 inspections across 3 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-02-17.
At a glance
Inspections
3
Sites
3
Observations
3
Career since
Feb 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany | 17 Feb 2023 | Human Drugs | View 483 → |
| Sun Pharmaceutical Industries Limited | 14 Sep 2018 | Human Drugs | On file |
| Lyophilization Services of New England, Inc. dba PCI Pharma Services | 15 Feb 2017 | Human Drugs |
Sites inspected
Halo Pharmaceutical, Inc. d/b/a Cambrex WhippanyWhippany, United States1 insp.
Sun Pharmaceutical Industries LimitedMohali, India1 insp.
Lyophilization Services of New England, Inc. dba PCI Pharma ServicesBedford, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Maotang Zhou's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site